Sector: MedicalValeant Pharmaceuticals International (NYSE: VRX)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 22 |
Technical : | 216 |
Performance : | 119 |
Overall: | 101 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 11 |
Technical : | 188 |
Performance : | 127 |
Overall: | 77 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 9 |
Technical : | 230 |
Performance : | 164 |
Overall: | 122 |
Number of Stocks: | 306 |
Headlines
- Patheon, Inc. announces the appointment of Francisco R. Negron as Vice President and general manager of its Puerto Rico operations
Nov 18, 2009 09:48 AM | PTI, VRX
- CED Sets Dates For Upcoming Conference Season
Nov 03, 2009 12:01 PM | GSK, TRGT, VRX
- Valeant Pharmaceuticals Highlights Taribavirin Phase IIb End of Study Data Presentation at American Association for the Study of Liver Disease (AASLD) Annual Meeting
Nov 03, 2009 08:03 AM | VRX
- Meda: Retigabine Filings Completed in the US and Europe
Nov 02, 2009 08:18 AM | GSK, VRX
- Valeant Pharmaceuticals Reports Third Quarter Financial Results
Nov 02, 2009 08:02 AM | VRX
- Valeant to Acquire Polish Products
Oct 30, 2009 08:01 AM | VRX
- Valeant Pharmaceuticals to Announce 2009 Third Quarter Results on November 2, 2009
Oct 23, 2009 04:30 PM | VRX
- Medivation Names Hank Mansbach, M.D., Vice President of Medical Affairs
Oct 23, 2009 08:01 AM | MDVN, VRX
- New Study Assesses Skin Hydration and Epidermal Function of 2.5% and 5% Benzoyl Peroxide-Clindamycin Combinations
Oct 20, 2009 08:00 AM | VRX
- Valeant to Acquire Major Australian Skincare Brands
Sep 30, 2009 08:02 AM | VRX
- State of the Art Electric Car Charging Stations Coming to Contra Costa County
Apr 04, 2009 12:51 PM | LSE, VRX
- Electric Car Sparking Back to Life: Once Declared Dead, the Electric Car Returns. Automakers Have Them in the Works, and the Zippy Tesla Leads the Way.
Mar 23, 2009 09:55 AM | DNA, GM, GOOG, LSE, MSBHY, MSFT
- Sparking Back to Life: Once Declared Dead, the Electric Car Returns. Automakers Have Them in the Works, and the Zippy Tesla Leads the Way.
Mar 23, 2009 03:59 AM | DNA, GM, GOOG, LSE, MSBHY, MSFT
- Electric Dreams: Slick Cycle Offers an Ecofriendly Alternative
Mar 17, 2009 10:57 AM | LSE, VRX
- Coria Laboratories Launches Acanya(TM) Gel
Mar 06, 2009 01:02 PM | VRX
- '08 Blade Stock Contest Leaves Only 5 Entrants in the Black
Jan 11, 2009 02:20 PM | AKNS, AMD, AMGN, AMKR, DNDN, EBS
- First All-Electric Scooters Charging Charlotte Market
Aug 14, 2008 08:52 PM | LSE, VRX
- RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on VRX, BBV, GMR, PRE, DB and PZE
Sep 29, 2009 07:10 AM | BBV, DB, GMR, PRE, PZE, VRX
- Valeant Pharmaceuticals Announces Preliminary Results From Its Phase IIa Retigabine Study for the Treatment of Postherpetic Neuralgia (PHN)
Aug 24, 2009 08:01 AM | VRX
- Valeant Pharmaceuticals Reports Second Quarter Financial Results
Aug 04, 2009 08:02 AM | VRX
- Valeant to Acquire Tecnofarma, A Mexican Generic Company
Jul 29, 2009 08:07 AM | VRX
- Valeant Pharmaceuticals to Announce 2009 Second Quarter Results on August 4, 2009
Jul 21, 2009 04:30 PM | VRX
- Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(R) ER in Canada, Australia and New Zealand; Agreement Demonstrates Value of OPANA ER in Markets Outside U.S.
Jun 09, 2009 08:02 AM | NVS, PPCO, VRX
- Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand
Jun 09, 2009 07:31 AM | ENDP, PPCO, VRX
- Valeant Announces Pricing of Senior Notes
Jun 04, 2009 08:02 AM | VRX
- Valeant Pharmaceuticals to Present at Goldman Sachs 30th Annual Global Healthcare Conference
Jun 02, 2009 08:04 AM | VRX
- Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study
Jun 01, 2009 08:15 AM | VRX
- Form 4 VALEANT PHARMACEUTICALS For: Nov 18 Filed by: HealthCor Hybrid Offshore GP, LLC (10K)
Nov 20, 2009 05:26 PM
- Form 4 VALEANT PHARMACEUTICALS For: Nov 18 Filed by: CHAUDHURI BHASKAR (10K)
Nov 19, 2009 02:33 PM
- Form 4 VALEANT PHARMACEUTICALS For: Nov 12 Filed by: Provencio Norma Ann (10K)
Nov 12, 2009 08:37 PM
- Form 4 VALEANT PHARMACEUTICALS For: Nov 10 Filed by: CHAUDHURI BHASKAR (10K)
Nov 12, 2009 04:22 PM
- Form 4 STEFANO STEPHEN F. For: Nov 04 (10K)
Nov 04, 2009 06:26 PM
- Form 4 STEFANO STEPHEN F. For: Oct 01 (10K)
Oct 05, 2009 08:06 PM
- Form 4 Provencio Norma Ann For: Oct 01 (10K)
Oct 05, 2009 08:06 PM
- Form 4 MELAS KYRIAZI THEO For: Oct 01 (10K)
Oct 05, 2009 08:04 PM
- Form 4 LONNER ANDERS For: Oct 01 (10K)
Oct 05, 2009 08:04 PM
- Form 4 KUGELMAN LARRY For: Oct 01 (10K)
Oct 05, 2009 08:03 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
VRX
|
Compare to S&P
|
| YTD |
45.33 %
|
20.28 %
|
| 4 Weeks |
10.13 %
|
8.94 %
|
| 12 Weeks |
30.31 %
|
22.85 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 13.73 %
|
|
EPS Growth in Last Year: 427.27 %
|
|
Sales Growth in Last Quarter: 14.93 %
|
|
Sales Growth in Last Quarter: 30.81 %
|
|
